The Human Anti-HCoV 229E IgA ELISA Kit is an immunoassay suitable for quantifying IgA antibody activity specific for S1 subunit of the spike protein of the HCoV 229E virus, etiologic agent for the COVID-19 respiratory disease, in serum or plasma of vaccinated, immunized and/or infected hosts.
This immunoassay is suitable for:
o Determining immune status relative to non-immune controls;
o Assessing efficacy of vaccines, including dosage, adjuvantcy, route of immunization, and timing;
o Qualifying and standardizing vaccine batches & protocols.
The assay is for research use only (RUO) and is not intended nor validated for diagnosing HCoV 229E virus disease. Reagents contain no virus or viral antigens.